Depression in women: Windows of vulnerability and new insights into the link between estrogen and serotonin

Journal of Clinical Psychiatry

Volumn 72, Issue 11, 2011, Pages

  Lokuge, Sonali ^a   Frey, Benicio N ^a,b   Foster, Jane A ^b,c   Soares, Claudio N ^a,b,c   Steiner, Meir ^a,b,c  

^a Women's Health Concerns Clinic   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c Brain Body Institute   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; MESSENGER RNA; PROGESTERONE; SEROTONIN;

DEPRESSION; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; FEMALE; HORMONE SUBSTITUTION; HUMAN; MEDICAL RESEARCH; MENARCHE; MENOPAUSAL SYNDROME; MENOPAUSE; MOLECULAR INTERACTION; MOOD DISORDER; NEUROBIOLOGY; NOTE; PATHOPHYSIOLOGY; POSTMENOPAUSE; PREGNANCY; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; PUERPERIUM; REGULATORY MECHANISM; SEX DIFFERENCE;

EID: 81755173947     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.11com07089     Document Type: Note

References (92)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.
2. Pincus HA, Pettit AR. The societal costs of chronic major depression. J Clin Psychiatry. 2001;62(suppl 6):5-9. PubMed (Pubitemid 32298431)
3. World Health Organization. The Global Burden of Disease: 2004 Update. Geneva, Switzerland: WHO Press; 2008.
4. Kessler RC. Epidemiology of women and depression. J Affect Disord. 2003;74(1):5-13. doi:10.1016/S0165-0327(02)0426-3 PubMed (Pubitemid 36329172)
5. Steiner M, Dunn E, Born L. Hormones and mood: from menarche to menopause and beyond. J Affect Disord. 2003;74(1):67-83. doi:10.1016/S0165-0327(02)0432-9 PubMed (Pubitemid 36324478)
6. Soares CN, Zitek B. Reproductive hormone sensitivity and risk for depression across the female life cycle: a continuum of vulnerability? J Psychiatry Neurosci. 2008;33(4):331-343. PubMed (Pubitemid 351977159)
7. Kessler RC, Walters EE. Epidemiology of DSM-III-R major depression and minor depression among adolescents and young adults in the National Comorbidity Survey. Depress Anxiety. 1998;7(1):3-14. doi:10.102/(SICI)1520-6394(198)7: 1〈3:AID-DA2〉3.0.CO;2-F PubMed (Pubitemid 28248515)
8. O'Brien PM, Bäckström T, Brown C, et al. Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus. Arch Women Ment Health. 2011;14(1):13-21. doi:10.107/s0737-010-0201-3 PubMed
9. Steiner M, Macdougall M, Brown E. The Premenstrual Symptoms Screening Tool (PSST) for clinicians. Arch Women Ment Health. 2003;6(3):203-209. doi:10.107/s0737-03-018-4 PubMed (Pubitemid 37046015)
10. Steiner M, Peer M, Palova E, et al. The Premenstrual Symptoms Screening Tool revised for adolescents (PSST-A): prevalence of severe PMS and premenstrual dysphoric disorder in adolescents. Arch Women Ment Health. 2011;14(1):77-81. doi:10.107/s0737-010-0202-2 PubMed
11. Wittchen HU, Becker E, Lieb R, et al. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med. 2002;32(1):119-132. doi:10.1017/S0329170104925 PubMed (Pubitemid 33150508)
12. Steiner M, Pearlstein T, Cohen LS, et al. Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs. J Womens Health (Larchmt). 2006;15(1):57-69. doi:10.1089/jwh.206.15.57 PubMed (Pubitemid 43192864)
13. Bennett HA, Einarson A, Taddio A, et al. Prevalence of depression during pregnancy: systematic review. Obstet Gynecol. 2004;103(4):698-709. doi:10.1097/01.AOG.01689.75396.5f PubMed (Pubitemid 40459031)
14. Nonacs R, Cohen LS. Depression during pregnancy: diagnosis and treatment options. J Clin Psychiatry. 2002;63(suppl 7):24-30. PubMed (Pubitemid 34454036)
15. Wu J, Viguera A, Riley L, et al. Mood disturbance in pregnancy and the mode of delivery. Am J Obstet Gynecol. 2002;187(4):864-867. doi:10.1067/mob.202. 127126 PubMed (Pubitemid 35178371)
16. Warner R, Appleby L, Whitton A, et al. Demographic and obstetric risk factors for postnatal psychiatric morbidity. Br J Psychiatry. 1996;168(5):607-611. doi:10.192/bjp.168.5.607 PubMed
17. Wisner KL, Moses-Kolko EL, Sit DK. Postpartum depression: a disorder in search of a definition. Arch Women Ment Health. 2010;13(1):37-40. doi:10.107/s0737-09-019-9 PubMed
18. Grace SL, Evindar A, Stewart DE. The effect of postpartum depression on child cognitive development and behavior: a review and critical analysis of the literature. Arch Women Ment Health. 2003;6(4):263-274. doi:10.107/s0737-03-024-6 PubMed (Pubitemid 37484381)
19. Streiner DL, Cairney J, Veldhuizen S. The epidemiology of psychological problems in the elderly. Can J Psychiatry. 2006;51(3):185-191. PubMed
20. Bromberger JT, Kravitz HM, Chang YF, et al. Major depression during and after the menopausal transition: Study of Women's Health Across the Nation (SWAN). Psychol Med. 2011;41(9):1879-1888. doi:10.1017/S0329171016X PubMed
21. Soares CN. Can depression be a menopause-associated risk? BMC Med. 2010;8(1):79. doi:10.186/1741-7015-8-79 PubMed
22. Cohen LS, Soares CN, Vitonis AF, et al. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry. 2006;63(4):385-390. doi:10.101/archpsyc.63.4.385 PubMed
23. Freeman EW, Sammel MD, Lin H, et al. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry. 2006;63(4):375-382. doi:10.101/archpsyc.63.4.375 PubMed
24. Bromberger JT, Schott LL, Kravitz HM, et al. Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women's Health Across the Nation (SWAN). Arch Gen Psychiatry. 2010;67(6):598-607. doi:10.101/archgenpsychiatry.2010.5 PubMed
25. Soules MR, Sherman S, Parrott E, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Fertil Steril. 2001;76(5):874-878. doi:10.1016/S015-0282(01)02909-0 PubMed (Pubitemid 33031310)
26. Santoro N, Brown JR, Adel T, et al. Characterization of reproductive hormonal dynamics in the perimenopause. J Clin Endocrinol Metab. 1996;81(4):1495-1501. doi:10.1210/jc.81.4.1495 PubMed (Pubitemid 26118582)
27. Bromberger JT, Meyer PM, Kravitz HM, et al. Psychologic distress and natural menopause: a multiethnic community study. Am J Public Health. 2001;91(9):1435-1442. doi:10.2105/AJPH.91.9.1435 PubMed (Pubitemid 32803329)
28. Booij L, Van der Does W, Benkelfat C, et al. Predictors of mood response to acute tryptophan depletion: a reanalysis. Neuropsychopharmacology. 2002;27(5):852-861. doi:10.1016/S0893-13X(02)0361-5 PubMed
29. Ellenbogen MA, Young SN, Dean P, et al. Mood response to acute tryptophan depletion in healthy volunteers: sex differences and temporal stability. Neuropsychopharmacology. 1996;15(5):465-474. doi:10.1016/S0893-13X(96)056-5 PubMed
30. Nishizawa S, Benkelfat C, Young SN, et al. Differences between males and females in rates of serotonin synthesis in human brain. Proc Natl Acad Sci U S A. 1997;94(10):5308-5313. doi:10.1073/pnas.94.10.5308 PubMed (Pubitemid 27214779)
31. Rubinow DR, Hoban MC, Grover GN, et al. Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects. Am J Obstet Gynecol. 1988;158(1):5-11. PubMed (Pubitemid 18043325)
32. Schmidt PJ, Nieman LK, Danaceau MA, et al. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med. 1998;338(4):209-216. doi:10.1056/NEJM198012380401 PubMed (Pubitemid 28047573)
33. Bloch M, Schmidt PJ, Danaceau M, et al. Effects of gonadal steroids in women with a history of postpartum depression. Am J Psychiatry. 2000;157(6):924-930. doi:10.176/api.ajp.157.6.924 PubMed (Pubitemid 30412343)
34. Freeman EW, Sammel MD, Liu L, et al. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry. 2004;61(1):62-70. doi:10.101/archpsyc.61.1.62 PubMed (Pubitemid 38044642)
35. Bloch M, Aharonov I, Ben Avi I, et al. Gonadal steroids and affective symptoms during in vitro fertilization: implication for reproductive mood disorders. Psychoneuroendocrinology. 2011;36(6):790-796. doi:10.1016/j.psyneuen. 2010.10.018 PubMed
36. Deroo BJ, Korach KS. Estrogen receptors and human disease. J Clin Invest. 2006;116(3):561-570. doi:10.172/JCI27987 PubMed (Pubitemid 43326860)
37. Klinge CM. Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res. 2001;29(14):2905-2919. doi:10.1093/nar/29.14.2905 PubMed (Pubitemid 32685217)
38. Wissink S, van der Burg B, Katzenellenbogen BS, et al. Synergistic activation of the serotonin-1A receptor by nuclear factor-kappa B and estrogen. Mol Endocrinol. 2001;15(4):543-552. doi:10.1210/me.15.4.543 PubMed (Pubitemid 32328129)
39. Russell KS, Haynes MP, Sinha D, et al. Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. Proc Natl Acad Sci U S A. 2000;97(11):5930-5935. doi:10.1073/pnas.97. 1.5930 PubMed (Pubitemid 30367501)
40. Bulayeva NN, Gametchu B, Watson CS. Quantitative measurement of estrogen-induced ERK 1 and 2 activation via multiple membraneinitiated signaling pathways. Steroids. 2004;69(3):181-192. doi:10.1016/j.steroids.203.12.03 PubMed (Pubitemid 38479391)
41. Wade CB, Robinson S, Shapiro RA, et al. Estrogen receptor (ER) alpha and ERbeta exhibit unique pharmacologic properties when coupled to activation of the mitogen-activated protein kinase pathway. Endocrinology. 2001;142(6):2336-2342. doi:10.1210/en.142.6.236 PubMed (Pubitemid 32473088)
42. Singh M, Sétáló G Jr, Guan X, et al. Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: convergence of estrogen and neurotrophin signaling pathways. J Neurosci. 1999;19(4):1179-1188. PubMed (Pubitemid 29088901)
43. Zivadinovic D, Watson CS. Membrane estrogen receptor-alpha levels predict estrogen-induced ERK1/2 activation in MCF-7 cells. Breast Cancer Res. 2005;7(1):R130-R144. doi:10.186/bcr959 PubMed
44. Honda K, Sawada H, Kihara T, et al. Phosphatidylinositol 3-kinase mediates neuroprotection by estrogen in cultured cortical neurons. J Neurosci Res. 2000;60(3):321-327. doi:10.102/(SICI)1097-4547(20501)60:3〈321:AID- JNR6〉3.0.CO;2-T PubMed (Pubitemid 30253595)
45. Moriarty K, Kim KH, Bender JR. Minireview: estrogen receptormediated rapid signaling. Endocrinology. 2006;147(12):5557-5563. doi:10.1210/en.206-0729 PubMed (Pubitemid 44833471)
46. Levin ER. Cellular functions of plasma membrane estrogen receptors. Steroids. 2002;67(6):471-475. doi:10.1016/S039-128X(01)0179-9 PubMed
47. Zivadinovic D, Gametchu B, Watson CS. Membrane estrogen receptor-alpha levels in MCF-7 breast cancer cells predict cAMP and proliferation responses. Breast Cancer Res. 2005;7(1):R101-R112. doi:10.186/bcr958 PubMed
48. Thomas P, Pang Y, Filardo EJ, et al. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology. 2005;146(2):624-632. doi:10.1210/en.204-1064 PubMed (Pubitemid 40129818)
49. Revankar CM, Cimino DF, Sklar LA, et al. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science. 2005;307(5715):1625- 1630. doi:10.126/science.106943 PubMed (Pubitemid 40354745)
50. Filardo EJ, Quinn JA, Frackelton AR Jr, et al. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol Endocrinol. 2002;16(1):70-84. doi:10.1210/me.16.1.70 PubMed (Pubitemid 34044499)
51. Filardo EJ, Thomas P. GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release. Trends Endocrinol Metab. 2005;16(8):362-367. doi:10.1016/j.tem.205.08.05 PubMed (Pubitemid 41338741)
52. Lokuge S, Frey BN, Foster JA, et al. The rapid effects of estrogen: a minireview. Behav Pharmacol. 2010;21(5-6):465-472. doi:10.1097/FBP. 0b013e3283da5c3 PubMed
53. Deecher D, Andree TH, Sloan D, et al. From menarche to menopause: exploring the underlying biology of depression in women experiencing hormonal changes. Psychoneuroendocrinology. 2008;33(1):3-17. doi:10.1016/j.psyneuen.207. 10.06 PubMed
54. Ortega-Corona BG, Valencia-Sánchez A, Kubli-Garfias C, et al. Hypothalamic monoamine oxidase activity in ovariectomized rats after sexual behavior restoration. Arch Med Res. 1994;25(3):337-340. PubMed (Pubitemid 24344930)
55. Chevillard C, Barden N, Saavedra JM. Estradiol treatment decreases type A and increases type B monoamine oxidase in specific brain stem areas and cerebellum of ovariectomized rats. Brain Res. 1981;222(1):177-181. doi:10.1016/06-893(81)9095-0 PubMed
56. Holschneider DP, Kumazawa T, Chen K, et al. Tissue-specific effects of estrogen on monoamine oxidase A and B in the rat. Life Sci. 1998;63(3):155-160. doi:10.1016/S024-3205(98)025-0 PubMed (Pubitemid 28305563)
57. Gundlah C, Lu NZ, Bethea CL. Ovarian steroid regulation of monoamine oxidase-A and -B mRNAs in the macaque dorsal raphe and hypothalamic nuclei. Psychopharmacology (Berl). 2002;160(3):271-282. doi:10.107/s0213-01-0959-0 PubMed (Pubitemid 34230679)
58. Smith LJ, Henderson JA, Abell CW, et al. Effects of ovarian steroids and raloxifene on proteins that synthesize, transport, and degrade serotonin in the raphe region of macaques. Neuropsychopharmacology. 2004;29(11):2035-2045. doi:10.1038/sj.np.130510 PubMed (Pubitemid 39486555)
59. Cichon S, Winge I, Mattheisen M, et al. Brain-specific tryptophan hydroxylase 2 (TPH2): a functional Pro206Ser substitution and variation in the 5′-region are associated with bipolar affective disorder. Hum Mol Genet. 2008;17(1):87-97. doi:10.1093/hmg/dm286 PubMed
60. Zhang X, Gainetdinov RR, Beaulieu JM, et al. Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron. 2005;45(1):11-16. doi:10.1016/j.neuron.204.12.014 PubMed (Pubitemid 40075345)
61. Zill P, Baghai TC, Zwanzger P, et al. SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression. Mol Psychiatry. 2004;9(11):1030-1036. doi:10.1038/sj.mp.401525 PubMed (Pubitemid 39524291)
62. Pecins-Thompson M, Brown NA, Kohama SG, et al. Ovarian steroid regulation of tryptophan hydroxylase mRNA expression in rhesus macaques. J Neurosci. 1996;16(21):7021-7029. PubMed (Pubitemid 26359381)
63. Walther DJ, Bader M. A unique central tryptophan hydroxylase isoform. Biochem Pharmacol. 2003;66(9):1673-1680. doi:10.1016/S06-2952(03)056-2 PubMed (Pubitemid 37249312)
64. Hiroi R, McDevitt RA, Neumaier JF. Estrogen selectively increases tryptophan hydroxylase-2 mRNA expression in distinct subregions of rat midbrain raphe nucleus: association between gene expression and anxiety behavior in the open field. Biol Psychiatry. 2006;60(3):288-295. doi:10.1016/j.biopsych.205.10. 019 PubMed (Pubitemid 44093439)
65. Sanchez RL, Reddy AP, Centeno ML, et al. A second tryptophan hydroxylase isoform, TPH-2 mRNA, is increased by ovarian steroids in the raphe region of macaques. Brain Res Mol Brain Res. 2005;135(1-2):194-203. doi:10.1016/j. molbrainres.204.12.01 PubMed (Pubitemid 40602411)
66. Donner N, Handa RJ. Estrogen receptor beta regulates the expression of tryptophan-hydroxylase 2 mRNA within serotonergic neurons of the rat dorsal raphe nuclei. Neuroscience. 2009;163(2):705-718. doi:10.1016/j.neuroscience.209. 06.046 PubMed
67. Sumner BE, Grant KE, Rosie R, et al. Effects of tamoxifen on serotonin transporter and 5-hydroxytryptamine(2A) receptor binding sites and mRNA levels in the brain of ovariectomized rats with or without acute estradiol replacement. Brain Res Mol Brain Res. 1999;73(1-2):119-128. doi:10.1016/S0169-328X(9)0243-0 PubMed
68. Fink G, Sumner BE, McQueen JK, et al. Sex steroid control of mood, mental state and memory. Clin Exp Pharmacol Physiol. 1998;25(10):764-775. doi:10.1/j.140-1681.198.tb02151.x PubMed (Pubitemid 28442678)
69. McQueen JK, Wilson H, Fink G. Estradiol-17 beta increases serotonin transporter (SERT) mRNA levels and the density of SERT-binding sites in female rat brain. Brain Res Mol Brain Res. 1997;45(1):13-23. doi:10.1016/S0169-328X(96) 023-1 PubMed
70. Pecins-Thompson M, Brown NA, Bethea CL. Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques. Brain Res Mol Brain Res. 1998;53(1-2):120-129. doi:10.1016/S0169-328X(97)0286-6 PubMed
71. Shively CA, Mirkes SJ, Lu NZ, et al. Soy and social stress affect serotonin neurotransmission in primates. Pharmacogenomics J. 2003;3(2):114-121. doi:10.1038/sj.tpj.65016 PubMed (Pubitemid 36675712)
72. Burnet PW, Harrison PJ. Genetic variation of the 5-HT2A receptor and response to clozapine. Lancet. 1995;346(8979):909. PubMed
73. Hall H, Lundkvist C, Halldin C, et al. Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635. Brain Res. 1997;745(1-2):96-108. doi:10.1016/S06-893(96)0131-6 PubMed (Pubitemid 27055749)
74. Osterlund MK, Hurd YL. Acute 17 beta-estradiol treatment down-regulates serotonin 5HT1A receptor mRNA expression in the limbic system of female rats. Brain Res Mol Brain Res. 1998;55(1):169-172. doi:10.1016/S0169-328X(98)018-7 PubMed
75. Osterlund MK, Halldin C, Hurd YL. Effects of chronic 17β-estradiol treatment on the serotonin 5-HT(1A) receptor mRNA and binding levels in the rat brain. Synapse. 2000;35(1):39-44. PubMed doi:10.102/(SICI)1098-2396(201)35: 1〈39:AID-SYN5〉3.0.CO;2-T
76. Pecins-Thompson M, Bethea CL. Ovarian steroid regulation of serotonin-1A autoreceptor messenger RNA expression in the dorsal raphe of rhesus macaques. Neuroscience. 1999;89(1):267-277. doi:10.1016/S0306-452(98)0326-1 PubMed (Pubitemid 29049044)
77. Lu NZ, Bethea CL. Ovarian steroid regulation of 5-HT1A receptor binding and G protein activation in female monkeys. Neuropsychopharmacology. 2002;27(1):12-24. doi:10.1016/S0893-13X(01)0423-7 PubMed
78. Barnes NM, Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology. 1999;38(8):1083-1152. doi:10.1016/S028-3908(9)010-6 PubMed (Pubitemid 29292403)
79. Summer BE, Fink G. Estrogen increases the density of 5- hydroxytryptamine(2A) receptors in cerebral cortex and nucleus accumbens in the female rat. J Steroid Biochem Mol Biol. 1995;54(1-2):15-20. doi:10.1016/0960- 0760(95)075-B PubMed
80. Halbreich U, Rojansky N, Palter S, et al. Estrogen augments serotonergic activity in postmenopausal women. Biol Psychiatry. 1995;37(7):434-441. doi:10.1016/06-323(94)0181-2 PubMed
81. Soares CN, Frey BN. Challenges and opportunities to manage depression during the menopausal transition and beyond. Psychiatr Clin North Am. 2010;33(2):295-308. doi:10.1016/j.psc.2010.01.07 PubMed
82. Moses EL, Drevets WC, Smith G, et al. Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: a PET study. Biol Psychiatry. 2000;48(8):854-860. doi:10.1016/S06-323(0)0967-7 PubMed
83. Kugaya A, Epperson CN, Zoghbi S, et al. Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women. Am J Psychiatry. 2003;160(8):1522-1524. doi:10.176/api.ajp.160.8.152 PubMed (Pubitemid 41070932)
84. Compton J, Travis MJ, Norbury R, et al. Long-term estrogen therapy and 5-HT(2A) receptor binding in postmenopausal women; a single photon emission tomography (SPET) study. Horm Behav. 2008;53(1):61-68. doi:10.1016/j.yhbeh.207. 08.014 PubMed (Pubitemid 350309366)
85. de Novaes Soares C, Almeida OP, Joffe H, et al. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry. 2001;58(6):529-534. doi:10.101/archpsyc.58.6.529 PubMed (Pubitemid 32523731)
86. Schmidt PJ, Nieman L, Danaceau MA, et al. Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol. 2000;183(2):414-420. doi:10.1067/mob.20.10604 PubMed (Pubitemid 30651090)
87. Hlatky MA, Boothroyd D, Vittinghoff E, et al. Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial. JAMA. 2002;287(5):591-597. doi:10.101/jama.287.5.591 PubMed (Pubitemid 34252010)
88. Morrison MF, Kallan MJ, Ten Have T, et al. Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial. Biol Psychiatry. 2004;55(4):406-412. doi:10.1016/j.biopsych.203.08.01 PubMed (Pubitemid 38199991)
89. Sacher J, Wilson AA, Houle S, et al. Elevated brain monoamine oxidase A binding in the early postpartum period. Arch Gen Psychiatry. 2010;67(5):468-474. doi:10.101/archgenpsychiatry.2010.32 PubMed
90. Sakai Y, Nishikawa M, Leyton M, et al. Cortical trapping of alpha-[(11)C] methyl-l-tryptophan, an index of serotonin synthesis, is lower in females than males. Neuroimage. 2006;33(3):815-824. doi:10.1016/j.neuroimage.206.08.04 PubMed (Pubitemid 44584762)
91. Frey BN, Skelin I, Sakai Y, et al. Gender differences in alpha-[(11)C] MTrp brain trapping, an index of serotonin synthesis, in medication-free individuals with major depressive disorder: a positron emission tomography study. Psychiatry Res. 2010;183(2):157-166. doi:10.1016/j.pscychresns.2010.05.05 PubMed
92. Pearlstein T, Rosen K, Stone AB. Mood disorders and menopause. Endocrinol Metab Clin North Am. 1997;26(2):279-294. doi:10.1016/S089-8529(05)70247-4 PubMed (Pubitemid 27265441)